GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first identified in human plasma by Loren Pickart in 1973. With over five decades of research behind it, GHK-Cu stands as one of the most thoroughly studied peptides in the fields of wound healing, tissue remodeling, and skin biology.
The peptide exists naturally in human plasma, saliva, and urine, with concentrations that decline significantly with age. In plasma, GHK-Cu levels drop from approximately 200 ng/mL at age 20 to roughly 80 ng/mL by age 60. This age-related decline has prompted researchers to investigate whether supplementation could restore biological functions associated with youthful tissue maintenance.
The wound healing properties of GHK-Cu were among the first to be characterized. Studies have demonstrated that the peptide accelerates wound contraction, stimulates collagen synthesis, promotes angiogenesis, and enhances the expression of decorin and other proteoglycans involved in tissue remodeling. These effects have been observed in multiple wound models, including dermal, bone, and gastric tissue.
At the molecular level, GHK-Cu has been shown to influence the expression of a remarkable number of genes. A landmark 2012 genomic study by Pickart and colleagues found that GHK-Cu modulated the expression of over 4,000 human genes — approximately 6% of the genome. Many of these genes are involved in tissue repair, antioxidant defense, and anti-inflammatory processes.
The anti-aging research on GHK-Cu has focused primarily on skin. Topical application studies have reported improvements in skin elasticity, firmness, and thickness, as well as reductions in fine lines, hyperpigmentation, and photodamage. The mechanisms are believed to involve increased collagen and elastin synthesis, enhanced glycosaminoglycan production, and improved antioxidant enzyme expression.
GHK-Cu's role in hair biology has also attracted attention. Research has shown that the peptide can increase hair follicle size, stimulate hair growth, and enhance the thickness of existing hair. These findings have been attributed to GHK-Cu's ability to promote angiogenesis around hair follicles and modulate growth factor signaling in the dermal papilla.
The copper component of GHK-Cu is integral to its biological activity. Copper ions serve as cofactors for numerous enzymes involved in tissue repair, including lysyl oxidase (essential for collagen cross-linking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (cellular energy production). GHK-Cu appears to serve as a bioavailable delivery system for copper to tissues.
Anti-inflammatory properties of GHK-Cu have been documented in several studies. The peptide has been shown to reduce levels of pro-inflammatory cytokines including TNF-α and IL-6, while increasing the expression of anti-inflammatory mediators. This dual activity — promoting repair while reducing inflammation — is a key feature of its biological profile.
Current research is exploring systemic applications of GHK-Cu beyond dermatology. Areas of investigation include neuroprotection (GHK-Cu has shown effects in models of cognitive decline), pulmonary fibrosis (the peptide may help remodel fibrotic tissue), and oncology (genomic studies suggest it may restore expression patterns associated with healthy tissue).
For researchers entering this field, GHK-Cu offers a compelling combination of a well-characterized safety profile, a rich historical research base, and emerging therapeutic applications. The continued decline of endogenous GHK-Cu with aging suggests that supplementation strategies may have broad relevance to age-related health decline.
